RxDoctor Payments Data

Jessie Goethie, APRN

Nurse Practitioner · Port Royal, SCNPI 1982100285

Payments from drug & device makers

$281in general payments, 2019–2025

Across 14 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$72
  • Lilly USA, LLC$72
  • Hologic Sales And Service, LLC$33
  • Pfizer$32
  • Boston Scientific$24
  • Merck$18
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$281100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$281 in reported general payments places this provider in the 65th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$143
Medicare patients
14
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala29$120,963
JardianceEmpagliflozin69$120,226
OzempicSemaglutide50$79,499
TrulicityDulaglutide39$55,933
EliquisApixaban46$48,986
TivicayDolutegravir Sodium20$46,385
FarxigaDapagliflozin Propanediol33$42,459
MounjaroTirzepatide33$41,927
JanuviaSitagliptin Phosphate22$37,230
DescovyEmtricitabine/Tenofov Alafenam11$28,101
PrezcobixDarunavir/Cobicistat12$27,757
XareltoRivaroxaban15$24,720
Tresiba Flextouch U-100Insulin Degludec19$11,790
Atorvastatin Calcium459$3,710
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$72$97,86072 claims
Novo NordiskOzempic$15$79,49950 claims
PfizerEliquis$32$48,98646 claims
MerckJanuvia$18$37,23022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Port Royal

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →